NCT00659412View on ClinicalTrials.gov

A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Psoriatic Arthritis
Interventions
DRUG

Alefacept

Intramuscular

DRUG

Methotrexate

Oral

DRUG

Placebo

Intramuscular

Trial Locations (27)

11042

Lake Success

14642

Rochester

20902

Wheaton

35294

Birmingham

98104

Seattle

107076

Moscow

115522

Moscow

150003

Yaroslavl

190068

Saint Petersburg

194044

Saint Petersburg

603600

Nizhny Novgorod

V8V 3P9

Victoria

A1C 5B8

St. John's

N6A 4V2

London

L3Y 3R7

Newmarket

K1N 5N1

Toronto

M5T 2S8

Toronto

H2L 1S6

Montreal

D-13125

Berlin

D-60590

Frankfurt

D-37075

Göttingen

15-337

Bialystok

82-300

Elblag

62-800

Kalisz

30-119

Krakow

87-100

Torun

02-637

Warsaw

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY